Breast Cancer Triple Negative Breast Cancer
1 clinical trials · Condition
◉ Watch Breast Cancer Triple Negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy (NCT07471815) | Harbin Medical University | 2026-03-04 |
Track Breast Cancer Triple Negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.